Last updated on February 2019

Phase 4, Single-Center, Multiple Dose, Open-Label Trial to evaluate the Efficacy of Additional Xiaflex Treatment in Patients with Peyronie's Disease Recurrence, Worsening, or Incomplete Response after Prior Xiaflez Treatment


Brief description of study

Phase 4, Single-Center, Multiple Dose, Open-Label Trial to evaluate the Efficacy of Additional Xiaflex Treatment in Patients with Peyronie's Disease Recurrence, Worsening, or Incomplete Response after Prior Xiaflez Treatment

 

Clinical Study Identifier: TX217997

Find a site near you

Start Over

Manhattan Medical Research

215 Lexington Avenue 21 Floor New York, New York United States
  Connect »